Progranulin mutations affects brain oscillatory activity in fronto-temporal dementia

Research output: Contribution to journalArticlepeer-review


Background: Mild cognitive impairment (MCI) is a clinical stage indicating a prodromal phase of dementia. This practical concept could be used also for fronto-temporal dementia (FTD). Progranulin (PGRN) has been recently recognized as a useful diagnostic biomarker for fronto-temporal lobe degeneration (FTLD) due to GRN null mutations. Electroencephalography (EEG) is a reliable tool in detecting brain networks changes. The working hypothesis of the present study is that EEG oscillations could detect different modifications among FTLD stages (FTD-MCI versus overt FTD) as well as differences between GRN mutation carriers versus non-carriers in patients with overt FTD. Materials and Methods: EEG in all patients and PGRN dosage in patients with a clear FTD were detected. The cognitive state has been investigated through mini mental state examination (MMSE). Results: MCI-FTD showed a significant lower spectral power in both alpha and theta oscillations as compared to overt FTD. GRN mutations carriers affected by FTLD show an increase in high alpha and decrease in theta oscillations as compared to non-carriers. Conclusion: EEG frequency rhythms are sensible to different stage of FTD and could detect changes in brain oscillatory activity affected by GRN mutations.

Original languageEnglish
Article number35
JournalFrontiers in Aging Neuroscience
Issue numberFEB
Publication statusPublished - 2016


  • EEG
  • FTD
  • PGRN negative
  • PGRN positive

ASJC Scopus subject areas

  • Ageing
  • Cognitive Neuroscience


Dive into the research topics of 'Progranulin mutations affects brain oscillatory activity in fronto-temporal dementia'. Together they form a unique fingerprint.

Cite this